Global Coronary Stents Market (2016-2022)

  • ID: 3951205
  • Report
  • Region: Global
  • 346 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Braun Melsungen AG
  • C. R. Bard, INC
  • Medtronic plc.
  • Stentys SA
  • Terumo Corporation
  • MORE
The Coronary stents market during the year 2015 was valued at USD 8,532.0 million, and the market is expected to rise and witness a CAGR of 6.9% during the forecast period. The demand for coronary stents can be attributed to growing incidences of cardiovascular disorders among the human population worldwide. Unhealthy lifestyle among working class has had a huge impact on the health. Due to unhealthy lifestyle among masses, the incidences of cardiovascular conditions have significantly increased over the years. Some of the leading causes of the condition are smoking, physical inactivity, and dietary changes among the masses. These lifestyle changes have led to greater possibility of hypertension, obesity, and blocks in arteries. As per CDC, it is found that 1/3 of the population in the United States is suffering from obesity, and is a leading cause for cardiovascular disorders. Such incidences in the US and around the world, has propelled the market growth and increased the demand for the vascular products.

The global coronary stent market was estimated to attain a market size of $8.5 billion in 2015 and is expected to grow at a CAGR of 6.9 % during the forecast period (2016 - 2022).

The North America region would continue its dominance and would attain a market size of $4.3 billion by 2022. The Drug Eluting Stents segment is expected to further grow at a CAGR of 6% during the forecast period thereby maintaining its dominance on the global market. However, the Bioresorable Vascular Scaffold segment would grow at the highest CAGR.

The report highlights the adoption of Coronary stents worldwide. Based on the product type; the Coronary stent market is segmented into Drug Eluting Stents (DES), Bare Metal Stents (BMS) and Bioresorbable Vascular Scaffold (BVS). Further the DES segment is sub segmented into Polymer free coatings and Polymer base coatings drug eluting stents market based on the drug coating type. The DES with Polymer free coatings segment is bifurcated into Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, Nanoporous Surface types. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).

Key market participants profiled in the report includes Abbott, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, Stentys SA, MicroPort Scientific Corporation and C. R. Bard, Inc.

The report aims at providing stakeholders with an in-depth analysis of the North America Coronary stents market. The current & future market trends of the technology are pinpointed in a highly strategic manner. With the report in hand, investors can gain highly strategic market insights to base their discretion for investments. Market estimation of the current market and estimations through 2016-2022 would provide the complete financial potency of the market.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Braun Melsungen AG
  • C. R. Bard, INC
  • Medtronic plc.
  • Stentys SA
  • Terumo Corporation
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Research Methodology

2. Executive Summary

3. Global Coronary Stents Market Overview
3.1 Key Influencing Factors
3.1.1 Market Drivers
3.1.2 Market Challenges
3.2 North America Coronary Stents Market
3.3 Europe Coronary Stents Market
3.4 Asia Pacific Coronary Stents Market
3.5 LAMEA Coronary Stents Market

4. Global Coronary Stent Market, By Product Type
4.1 Global Drug Eluting Stents Market
4.1.1 North America Drug Eluting Stents Market
4.1.2 Europe Drug Eluting Stents Market
4.1.3 Asia Pacific Drug Eluting Stents Market
4.1.4 LAMEA Drug Eluting Stents Market
4.2 Global Bare Metal Stents Market
4.2.1 North America Bare Metal Stents Market
4.2.2 Europe Bare Metal Stents Market
4.2.3 Asia Pacific Bare Metal Stents Market
4.2.4 LAMEA Bare Metal Stents Market
4.3 Global Bioresorable Vascular Scaffold Stents Market
4.3.1 North America Bioresorable Vascular Scaffold Stents Market
4.3.2 Europe Bioresorable Vascular Scaffold Stents Market
4.3.3 Asia Pacific Bioresorable Vascular Scaffold Stents Market
4.3.4 LAMEA Bioresorable Vascular Scaffold Stents Market

5. Global Drug Eluting Stents Market - By Type
5.1 Global Polymer Free Coatings Des Stents Market
5.1.1.1 North America Polymer Free Coatings Des Market
5.1.1.2 Europe Polymer Free Coatings Des Stents Market
5.1.1.3 Asia Pacific Polymer Free Coatings Des Stents Market
5.1.1.4 LAMEA Polymer Free Coatings Des Stents Market
5.1.2 Global Polymer Free Coatings Des Stents Market - By Type
5.1.2.1 Global Micro Porous Surface Based Des Market
5.1.2.2 Global Micro Structured Surface Based Des Market
5.1.2.3 Global Slotted Tubular Surface Based Des Market
5.1.2.4 Global Nanoporous Surface Based Des Market
5.1.2.5 North America Polymer Free Coatings Des Market - By Type
5.1.2.5.1 North America Micro Porous Surface Coatings Des Market
5.1.2.5.2 North America Micro Structured Surface Coatings Des Market
5.1.2.5.3 North America Slotted Tubular Surface Coatings Des Market
5.1.2.5.4 North America Nanoporous Surface Coatings Des Market
5.1.2.6 Europe Polymer Free Coatings Des Market - By Type
5.1.2.6.1 Europe Micro Porous Surface Coatings Des Market
5.1.2.6.2 Europe Micro Structured Surface Coatings Des Market
5.1.2.6.3 Europe Slotted Tubular Surface Coatings Des Market
5.1.2.6.4 Europe Nanoporous Surface Coatings Des Market
5.1.2.7 Asia Pacific Polymer Free Coatings Des Market - By Type
5.1.2.7.1 Asia Pacific Micro Porous Surface Coatings Des Market
5.1.2.7.2 Asia Pacific Micro Structured Surface Coatings Des Market
5.1.2.7.3 Asia Pacific Slotted Tubular Surface Coatings Des Market
5.1.2.7.4 Asia Pacific Nanoporous Surface Coatings Des Market
5.1.2.8 LAMEA Polymer Free Coatings Des Market - By Type
5.1.2.8.1 LAMEA Micro Porous Surface Coatings Des Market
5.1.2.8.2 LAMEA Micro Structured Surface Coatings Des Market
5.1.2.8.3 LAMEA Slotted Tubular Surface Coatings Des Market
5.1.2.8.4 LAMEA Nanoporous Surface Coatings Des Market
5.2 Global Polymer Based Coatings Des Stents Market
5.2.1 North America Polymer Based Coatings Des Stents Market
5.2.2 Europe Polymer Based Coatings Des Stents Market
5.2.3 Asia Pacific Polymer Based Coatings Des Stents Market
5.2.4 LAMEA Polymer Based Coatings Des Stents Market

6. Global Coronary Stents Market - By Geography
6.1 North America Coronary Stents Market
6.1.1 North America Coronary Stents Market - By Product Type
6.1.1.1 North America Drug Eluting Stents (DES) Market
6.1.1.1.1 North America Drug Eluting Stents (DES) Market - By Country
6.1.1.2 North America Bare Metal Stents (BMS) Market
6.1.1.2.1 North America Bare Metal Stents (BMS) Market - By Country
6.1.1.3 North America Bioresorable Vascular Scaffold (BVS) Market
6.1.1.3.1 North America Bioresorable Vascular Scaffold (BVS) Market - By Country
6.1.1.4 North America Drug Eluting Stents (DES) Market - By Type
6.1.1.4.1 North America Polymer Free Coatings DES Market
6.1.1.4.2 North America Polymer Based Coatings DES Market
6.1.2 North America Coronary Stents Market - By Country
6.1.2.1 U.S Coronary Stents Market
6.1.2.1.1 U.S Coronary Stents Market - By Product Type
6.1.2.2 Canada Coronary Stents Market
6.1.2.2.1 Canada Coronary Stents Market - By Product Type
6.1.2.3 Mexico Coronary Stents Market
6.1.2.3.1 Mexico Coronary Stents Market - By Product Type
6.1.2.4 Rest of North America Coronary Stents Market
6.1.2.4.1 Rest of North America Coronary Stents Market - By Product Type
6.2 Europe Coronary Stents Market
6.2.1 Europe Coronary Stents Market - By Product Type
6.2.1.1 Europe Drug Eluting Stents (DES) Market
6.2.1.1.1 Europe Drug Eluting Stents (DES) Market - By Country
6.2.1.1.2 Europe Drug Eluting Stents (DES) Market - By Type
6.2.1.2 Europe Bare Metal Stents (BMS) Market
6.2.1.2.1 Europe Bare Metal Stents (BMS) Market - By Country
6.2.1.3 Europe Bioresorable Vascular Scaffold (BVS) Market
6.2.1.3.1 Europe Bioresorable Vascular Scaffold (BVS) Market - By Country
6.2.2 Europe Coronary Stents Market - By Country
6.2.2.1 Germany Coronary Stents Market
6.2.2.1.1 Germany Coronary Stents Market - By Product Type
6.2.2.2 UK Coronary Stents Market
6.2.2.2.1 UK Coronary Stents Market - By Product Type
6.2.2.3 France Coronary Stents Market
6.2.2.3.1 France Coronary Stents Market - By Product Type
6.2.2.4 Russia Coronary Stents Market
6.2.2.4.1 Russia Coronary Stents Market - By Product Type
6.2.2.5 Spain Coronary Stents Market
6.2.2.5.1 Spain Coronary Stents Market - By Product Type
6.2.2.6 Italy Coronary Stents Market
6.2.2.6.1 Italy Coronary Stents Market - By Product Type
6.2.2.7 Rest of Europe Coronary Stents Market
6.2.2.7.1 Rest of Europe Coronary Stents Market - By Product Type
6.3 Asia Pacific Coronary Stents Market
6.3.1 Asia Pacific Coronary Stents Market - By Product Type
6.3.1.1 Asia Pacific Drug Eluting Stents (DES) Market
6.3.1.1.1 Asia Pacific Drug Eluting Stents (DES) Market - By Country
6.3.1.1.2 Asia Pacific Drug Eluting Stents (DES) Market - By Type
6.3.1.2 Asia Pacific Bare Metal Stents (BMS) Market
6.3.1.2.1 Asia Pacific Bare Metal Stents (BMS) Market - By Country
6.3.1.3 Asia Pacific Bioresorable Vascular Scaffold (BVS) Market
6.3.1.3.1 Asia Pacific Bioresorable Vascular Scaffold (BVS) Market - By Country
6.3.2 Asia Pacific Coronary Stents Market - By Country
6.3.2.1 China Coronary Stents Market
6.3.2.1.1 China Coronary Stents Market - By Product Type
6.3.2.2 Japan Coronary Stents Market
6.3.2.2.1 Japan Coronary Stents Market - By Product Type
6.3.2.3 India Coronary Stents Market
6.3.2.3.1 India Coronary Stents Market - By Product Type
6.3.2.4 South Korea Coronary Stents Market
6.3.2.4.1 South Korea Coronary Stents Market - By Product Type
6.3.2.5 Australia Coronary Stents Market
6.3.2.5.1 Australia Coronary Stents Market - By Product Type
6.3.2.6 Malaysia Coronary Stents Market
6.3.2.6.1 Malaysia Coronary Stents Market - By Product Type
6.3.2.7 Rest of Asia Pacific Coronary Stents Market
6.3.2.7.1 Rest of Asia Pacific Coronary Stents Market - By Product Type
6.4 LAMEA Coronary Stents Market
6.4.1 LAMEA Coronary Stents Market - By Product Type
6.4.1.1 LAMEA Drug Eluting Stents (DES) Market
6.4.1.1.1 LAMEA Drug Eluting Stents (DES) Market - By Country
6.4.1.1.2 LAMEA Drug Eluting Stents (DES) Market - By Type
6.4.1.2 LAMEA Bare Metal Stents (BMS) Market
6.4.1.2.1 LAMEA Bare Metal Stents (BMS) Market - By Country
6.4.1.3 LAMEA Bioresorable Vascular Scaffold (BVS) Market
6.4.1.3.1 LAMEA Bioresorable Vascular Scaffold (BVS) Market - By Country
6.4.2 LAMEA Coronary Stents Market - By Country
6.4.2.1 Brazil Coronary Stents Market
6.4.2.1.1 Brazil Coronary Stents Market - By Product Type
6.4.2.2 Argentina Coronary Stents Market
6.4.2.2.1 Argentina Coronary Stents Market - By Product Type
6.4.2.3 UAE Coronary Stents Market
6.4.2.3.1 UAE Coronary Stents Market - By Product Type
6.4.2.4 Saudi Arabia Coronary Stents Market
6.4.2.4.1 Saudi Arabia Coronary Stents Market - By Product Type
6.4.2.5 South Africa Coronary Stents Market
6.4.2.5.1 South Africa Coronary Stents Market - By Product Type
6.4.2.6 Nigeria Coronary Stents Market
6.4.2.6.1 Nigeria Coronary Stents Market - By Product Type
6.4.2.7 Rest of LAMEA Coronary Stents Market
6.4.2.7.1 Rest of LAMEA Coronary Stents Market - By Product Type

7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development
7.3 Medtronic plc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development
7.4 Terumo Corporation.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development
7.5 Braun Melsungen AG.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development
7.6 Stentys SA.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development
7.7 MicroPort Scientific Corporation.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Research & Development
7.8 C. R. Bard, INC.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc.
- Terumo Corporation
- Braun Melsungen AG
- Stentys SA
- MicroPort Scientific Corporation
- C. R. Bard, INC
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll